ORAMED PHARMACEUTICALS INC. Cash and Cash Equivalents, Period Increase (Decrease)
ORAMED PHARMACEUTICALS INC. (ORMP) reported Cash and Cash Equivalents, Period Increase (Decrease) of $2.60 million for the 6-month period ending 2020-02-29, per its 10-Q filed 2020-04-06.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2020-04-06
- ORAMED PHARMACEUTICALS INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2020-02-29 was $2.76M.
- ORAMED PHARMACEUTICALS INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2019-11-30 was -$158.00K.
- ORAMED PHARMACEUTICALS INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2019-08-31 was -$617.00K, a 146.64% decline year-over-year.
- ORAMED PHARMACEUTICALS INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2019-05-31 was $517.00K, a 36.77% increase year-over-year.
- ORAMED PHARMACEUTICALS INC. cash and cash equivalents, period increase (decrease) for fiscal 2019 was -$1.67M, a 262.32% decline from fiscal 2018.
- ORAMED PHARMACEUTICALS INC. cash and cash equivalents, period increase (decrease) for fiscal 2018 was $1.03M, a 1556.45% increase from fiscal 2017.
- ORAMED PHARMACEUTICALS INC. cash and cash equivalents, period increase (decrease) for fiscal 2017 was $62.00K, a 91.07% decline from fiscal 2016.
- ORAMED PHARMACEUTICALS INC. cash and cash equivalents, period increase (decrease) for fiscal 2016 was $694.00K, a 52.17% decline from fiscal 2015.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 3 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 12 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 116 month | Cash and Cash Equivalents, Period Increase (Decrease) 119 month | Cash and Cash Equivalents, Period Increase (Decrease) 122 month | Cash and Cash Equivalents, Period Increase (Decrease) 125 month | Cash and Cash Equivalents, Period Increase (Decrease) 131 month | Cash and Cash Equivalents, Period Increase (Decrease) 134 month | Cash and Cash Equivalents, Period Increase (Decrease) 137 month | Cash and Cash Equivalents, Period Increase (Decrease) 140 month | Cash and Cash Equivalents, Period Increase (Decrease) 143 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2020-02-29 | $2.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-04-06 | $2.60M 10-Q · filed 2020-04-06 | $1.99M derived: sum of 3 quarters · filed 2020-04-06 | $2.50M derived: sum of 4 quarters · filed 2020-04-06 | |||||||||||||
| 2019-11-30 | -$158.00K 10-Q · filed 2020-01-09 | -$775.00K derived: sum of 2 quarters · filed 2020-01-09 | -$258.00K derived: sum of 3 quarters · filed 2020-01-09 | -$690.00K derived: sum of 4 quarters · filed 2020-04-06 | |||||||||||||
| 2019-08-31 | -$617.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-11-27 | -$100.00K derived: sum of 2 quarters · filed 2019-11-27 | -$532.00K derived: sum of 3 quarters · filed 2020-04-06 | -$1.67M 10-K · filed 2019-11-27 | |||||||||||||
| 2019-05-31 | $517.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-07-10 | $85.00K derived: sum of 2 quarters · filed 2020-04-06 | -$1.05M 10-Q · filed 2019-07-10 | $273.00K derived: sum of 4 quarters · filed 2020-04-06 | |||||||||||||
| 2019-02-28 | -$432.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-04-06 | -$1.57M 10-Q · filed 2020-04-06 | -$244.00K derived: sum of 3 quarters · filed 2020-04-06 | $134.00K derived: sum of 4 quarters · filed 2020-04-06 | |||||||||||||
| 2018-11-30 | -$1.14M 10-Q · filed 2020-01-09 | $188.00K derived: sum of 2 quarters · filed 2020-01-09 | $566.00K derived: sum of 3 quarters · filed 2020-01-09 | $2.60M derived: sum of 4 quarters · filed 2020-01-09 | |||||||||||||
| 2018-08-31 | $1.32M derived: 10-K 12 month − 10-Q 9 month · filed 2019-11-27 | $1.70M derived: sum of 2 quarters · filed 2019-11-27 | $3.74M derived: sum of 3 quarters · filed 2019-11-27 | $1.03M 10-K · filed 2019-11-27 | |||||||||||||
| 2018-05-31 | $378.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-07-10 | $2.42M derived: sum of 2 quarters · filed 2019-07-10 | -$296.00K 10-Q · filed 2019-07-10 | $1.94M derived: sum of 4 quarters · filed 2019-11-27 | |||||||||||||
| 2018-02-28 | $2.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-04-10 | -$674.00K 10-Q · filed 2019-04-10 | $1.56M derived: sum of 3 quarters · filed 2019-11-27 | $1.84M derived: sum of 4 quarters · filed 2019-11-27 | |||||||||||||
| 2017-11-30 | -$2.71M 10-Q · filed 2019-01-14 | -$475.00K derived: sum of 2 quarters · filed 2019-11-27 | -$194.00K derived: sum of 3 quarters · filed 2019-11-27 | -$1.03M derived: sum of 4 quarters · filed 2019-11-27 | |||||||||||||
| 2017-08-31 | $2.24M derived: 10-K 12 month − 10-Q 9 month · filed 2019-11-27 | $2.52M derived: sum of 2 quarters · filed 2019-11-27 | $1.68M derived: sum of 3 quarters · filed 2019-11-27 | $62.00K 10-K · filed 2019-11-27 | |||||||||||||
| 2017-05-31 | $281.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-07-12 | -$557.00K derived: sum of 2 quarters · filed 2018-07-12 | -$2.17M 10-Q · filed 2018-07-12 | -$1.57M derived: sum of 4 quarters · filed 2018-11-28 | |||||||||||||
| 2017-02-28 | -$838.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-04-09 | -$2.46M 10-Q · filed 2018-04-09 | -$1.85M derived: sum of 3 quarters · filed 2018-11-28 | -$1.78M derived: sum of 4 quarters · filed 2018-11-28 | |||||||||||||
| 2016-11-30 | -$1.62M 10-Q · filed 2018-01-11 | -$1.01M derived: sum of 2 quarters · filed 2018-11-28 | -$940.00K derived: sum of 3 quarters · filed 2018-11-28 | $341.00K derived: sum of 4 quarters · filed 2018-11-28 | |||||||||||||
| 2016-08-31 | $605.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-11-28 | $677.00K derived: sum of 2 quarters · filed 2018-11-28 | $1.96M derived: sum of 3 quarters · filed 2018-11-28 | $694.00K 10-K · filed 2018-11-28 | |||||||||||||
| 2016-05-31 | $72.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-07-06 | $1.35M derived: sum of 2 quarters · filed 2017-07-06 | $89.00K 10-Q · filed 2017-07-06 | -$545.00K derived: sum of 4 quarters · filed 2017-11-29 | |||||||||||||
| 2016-02-29 | $1.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-04-05 | $17.00K 10-Q · filed 2017-04-05 | -$617.00K derived: sum of 3 quarters · filed 2017-11-29 | $2.13M derived: sum of 4 quarters · filed 2017-11-29 | |||||||||||||
| 2015-11-30 | -$1.26M 10-Q · filed 2017-01-11 | -$1.90M derived: sum of 2 quarters · filed 2017-11-29 | $847.00K derived: sum of 3 quarters · filed 2017-11-29 | -$4.71M derived: sum of 4 quarters · filed 2017-11-29 | |||||||||||||
| 2015-08-31 | -$634.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-11-29 | $2.11M derived: sum of 2 quarters · filed 2017-11-29 | -$3.44M derived: sum of 3 quarters · filed 2017-11-29 | $1.45M 10-K · filed 2017-11-29 | |||||||||||||
| 2015-05-31 | $2.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-07-06 | -$2.81M derived: sum of 2 quarters · filed 2016-07-06 | $2.08M 10-Q · filed 2016-07-06 | $1.37M derived: sum of 4 quarters · filed 2016-11-25 | |||||||||||||
| 2015-02-28 | -$5.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-04-06 | -$660.00K 10-Q · filed 2016-04-06 | -$1.37M derived: sum of 3 quarters · filed 2016-11-25 | -$2.15M derived: sum of 4 quarters · filed 2016-11-25 | |||||||||||||
| 2014-11-30 | $4.89M 10-Q · filed 2016-01-13 | $4.18M derived: sum of 2 quarters · filed 2016-11-25 | $3.40M derived: sum of 3 quarters · filed 2016-11-25 | $5.29M derived: sum of 4 quarters · filed 2016-11-25 | |||||||||||||
| 2014-08-31 | -$713.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-11-25 | -$1.49M derived: sum of 2 quarters · filed 2016-11-25 | $391.00K derived: sum of 3 quarters · filed 2016-11-25 | -$510.00K 10-K · filed 2016-11-25 | |||||||||||||
| 2014-05-31 | -$778.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-07-01 | $1.10M derived: sum of 2 quarters · filed 2015-07-01 | $203.00K 10-Q · filed 2015-07-01 | $202.61K 10-Q · filed 2014-07-14 | $1.37M derived: sum of 4 quarters · filed 2015-11-25 | ||||||||||||
| 2014-02-28 | $1.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-04-03 | $981.00K 10-Q · filed 2015-04-03 | $980.68K 10-Q · filed 2014-04-10 | $2.15M derived: sum of 3 quarters · filed 2015-11-25 | $1.21M derived: sum of 4 quarters · filed 2015-11-25 | $3.25M 10-Q · filed 2014-04-10 | |||||||||||
| 2013-11-30 | -$901.00K 10-Q · filed 2015-01-08 | -$901.48K 10-Q · filed 2014-01-14 | $265.84K derived: sum of 2 quarters · filed 2015-11-25 | -$669.16K derived: sum of 3 quarters · filed 2015-11-25 | -$4.16M derived: sum of 4 quarters · filed 2015-11-25 | $1.37M 10-Q · filed 2014-01-14 | |||||||||||
| 2013-08-31 | $1.17M derived: 10-K 12 month − 10-Q 9 month · filed 2015-11-25 | $231.84K derived: sum of 2 quarters · filed 2015-11-25 | -$3.26M derived: sum of 3 quarters · filed 2015-11-25 | -$2.16M 10-K · filed 2015-11-25 | -$2.16M 10-K · filed 2013-11-27 | $2.27M 10-K · filed 2013-11-27 | |||||||||||
| 2013-05-31 | -$935.01K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-07-14 | -$4.43M derived: sum of 2 quarters · filed 2014-07-14 | -$3.33M 10-Q · filed 2014-07-14 | -$194.34K derived: sum of 4 quarters · filed 2014-11-14 | $1.10M 10-Q · filed 2013-07-17 | ||||||||||||
| 2013-02-28 | -$3.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-04-10 | -$2.39M 10-Q · filed 2014-04-10 | $740.66K derived: sum of 3 quarters · filed 2014-11-14 | $216.39K derived: sum of 4 quarters · filed 2014-11-14 | $2.04M 10-Q · filed 2013-04-11 | ||||||||||||
| 2012-11-30 | $1.10M 10-Q · filed 2014-01-14 | $4.23M derived: sum of 2 quarters · filed 2014-11-14 | $3.71M derived: sum of 3 quarters · filed 2014-11-14 | $4.04M derived: sum of 4 quarters · filed 2014-11-14 | |||||||||||||
| 2012-08-31 | $3.13M derived: 10-K 12 month − 10-Q 9 month · filed 2014-11-14 | $2.61M derived: sum of 2 quarters · filed 2014-11-14 | $2.94M derived: sum of 3 quarters · filed 2014-11-14 | $2.92M 10-K · filed 2014-11-14 | $2.92M 10-K · filed 2012-12-12 | $4.43M 10-K · filed 2012-12-12 | |||||||||||
| 2012-05-31 | -$524.28K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-07-17 | -$195.75K derived: sum of 2 quarters · filed 2013-07-17 | -$213.50K 10-Q · filed 2013-07-17 | -$620.27K derived: sum of 4 quarters · filed 2013-07-17 | $1.30M 10-Q · filed 2012-07-12 | ||||||||||||
| 2012-02-29 | $328.53K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-04-11 | $310.78K 10-Q · filed 2013-04-11 | -$95.99K derived: sum of 3 quarters · filed 2013-04-11 | -$107.62K derived: sum of 4 quarters · filed 2013-04-11 | $1.82M 10-Q · filed 2012-04-04 | ||||||||||||
| 2011-11-30 | -$17.75K 10-Q · filed 2012-01-12 | -$424.52K derived: sum of 2 quarters · filed 2012-12-12 | -$436.15K derived: sum of 3 quarters · filed 2012-12-12 | $394.33K derived: sum of 4 quarters · filed 2012-12-12 | $1.50M 10-Q · filed 2012-01-12 | ||||||||||||
| 2011-08-31 | -$406.77K derived: 10-K 12 month − 10-Q 9 month · filed 2012-12-12 | -$418.40K derived: sum of 2 quarters · filed 2012-12-12 | $412.08K derived: sum of 3 quarters · filed 2012-12-12 | $313.73K 10-K · filed 2012-12-12 | |||||||||||||
| 2011-05-31 | -$11.63K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-07-12 | $818.85K derived: sum of 2 quarters · filed 2012-07-12 | $720.49K 10-Q · filed 2012-07-12 | ||||||||||||||
| 2011-02-28 | $830.48K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-04-04 | $732.12K 10-Q · filed 2012-04-04 | |||||||||||||||
| 2010-11-30 | -$98.36K 10-Q · filed 2012-01-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |